PHARMACY

Amgen's Kyprolis' new dosing option gets FDA nod
Amgen's Kyprolis now offers patients with relapsed or refractory multiple myeloma the option of a more convenient dosing regime.
Lupin receives FDA blessing for generic Pulmicort
Lupin has received the FDA's nod for generic Pulmicort, which had a market value of about $474.5 million.

Theravance Biopharma, Mylan get FDA approval for Yupelri

Yupelri is the first and only once-daily nebulized bronchodilator approved for the treatment of COPD, the companies said.
Lupin launches generic Mepron

Lupin is debuting a generic version of GlaxoSmithKline’s Mepron, which had a market value of about $119 million, according to IQVIA data.
Amneal, Lannett complete transition agreement for generic levothyroxine

Amneal’s agreement with Lannett accelerates the company's launch of the generic thyroid drug, levothyroxine.
FDA touts record-breaking number of October generic approvals

The Food and Drug Administration approved 110 generic drugs and tentatively approved 18 generic drugs for a total of 128 approval actions throughout the month of October.
FDA approved clobazam oral film formulation

Sympazan is the first clobazam oral film formulation approved by the Food and Drug Administration, maker Aquestive Therapeutics said.
PhRMA to roll out ‘Roadmap to Health’ in NYC

The Pharmaceutical Research and Manufacturers of America is sponsoring a new mobile health screening program next year to address chronic disease in New York City.
Hikma, Vectura to develop generic versions of GSK’s Ellipta portfolio

Hikma and Vectura plan to develop generic versions of GSK's Ellipta portfolio, utilizing Vectura's proprietary "open-inhale-close" dry powder inhaler device.
Genoa Healthcare debuts 14 pharmacies

With the opening of 14 new pharmacies, Genoa Healthcare has a total of 437 pharmacies.